Basilea Pharmaceutica AG (SWX: BSLN)

Basilea Pharmaceutica AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	14.28	14.21	24.07	28.62	28.39	20.8
Cash & Short-Term Investments	14.28	14.21	24.07	28.62	28.39	20.8
Cash Growth	-15.33%	-40.96%	-15.92%	0.83%	36.47%	13.46%
Accounts Receivable	9.16	6.41	2.82	1.69	1.04	0.76
Other Receivables	1.83	1.21	0.8	0.36	0.37	0.32
Receivables	10.98	7.62	3.62	2.05	1.4	1.08
Inventory	6.85	4.86	3.17	1.76	1.46	0.95
Prepaid Expenses	1.13	0.51	0.54	0.47	0.55	0.46
Other Current Assets	-	-	-	-	2.17	-
Total Current Assets	33.24	27.19	31.39	32.89	33.97	23.29
Property, Plant & Equipment	2.94	2.64	2.32	2.45	2.59	2.78
Goodwill	24.74	24.47	29.31	33.39	33.85	33.86
Other Intangible Assets	16.17	16.51	19.41	22.61	23.67	27.92
Long-Term Deferred Tax Assets	0.1	0.64	0.5	-	0.3	-
Other Long-Term Assets	0.11	0.01	-	-	-	-
Total Assets	77.3	71.46	82.95	91.34	94.36	87.85
Accounts Payable	2.83	1.3	1.3	0.85	0.94	1.06
Accrued Expenses	8.73	7.87	4.96	3.6	2.59	2.29
Current Portion of Leases	0.61	0.65	0.48	0.38	0.35	0.29
Other Current Liabilities	-	3.38	5.84	6.46	-	-
Total Current Liabilities	12.17	13.19	12.59	11.29	3.88	3.64
Long-Term Leases	1.36	1.57	1.5	1.83	2.06	2.14
Long-Term Deferred Tax Liabilities	-	-	-	0.89	3.24	3.49
Total Liabilities	17.13	14.75	14.09	14.36	9.76	10
Common Stock	3.71	3.68	3.66	3.28	32.81	22.47
Additional Paid-In Capital	74.11	73.32	160.16	154.59	125.06	118.16
Retained Earnings	-42.28	-42.15	-115.83	-101.59	-94.27	-81.9
Treasury Stock	-0.02	-0.02	-0.02	-0.02	-0.02	-0.02
Comprensive Income & Other	24.65	21.89	20.9	20.71	21.02	19.15
Shareholders' Equity	60.18	56.71	68.86	76.98	84.6	77.86
Total Liabilities & Equity	77.3	71.46	82.95	91.34	94.36	87.85
Total Debt	1.96	2.21	1.98	2.21	2.41	2.44
Net Cash (Debt)	12.31	12	22.09	26.41	25.98	18.37
Net Cash Growth	-12.01%	-45.67%	-16.38%	1.66%	41.45%	0.17%
Net Cash Per Share	0.42	0.33	0.65	0.81	1.07	1.16
Filing Date Shares Outstanding	21.1	36.77	36.54	32.79	32.79	22.45
Total Common Shares Outstanding	21.1	36.77	36.54	32.79	32.79	22.45
Working Capital	21.08	14.01	18.8	21.6	30.09	19.65
Book Value Per Share	2.85	1.54	1.88	2.35	2.58	3.47
Tangible Book Value	19.27	15.74	20.13	20.98	27.09	16.08
Tangible Book Value Per Share	0.91	0.43	0.55	0.64	0.83	0.72
Machinery	2.38	1.75	1.51	1.18	0.94	0.88
Leasehold Improvements	0.07	0.04	0.04	0.04	0.04	0.04

Source: S&P Capital IQ. Standard template. Financial Sources.